[1] Tirzepatide (Mounjaro, Zepbound) has a half-life of approximately 5 days, with elimination taking about 4-5 weeks after the last dose
If your sleep disruption involves frequent awakenings, difficulty maintaining sleep, or non-restorative sleep despite adequate duration, neuroprotective peptides targeting brain health may address the underlying issue
It damages Pericytes: These cells form the walls of the tiny blood vessels feeding the nerve
This activation stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and most significantly for weight management, reduces appetite through effects on hypothalamic appetite centers
6.3 Cardiovascular diseases Cardiovascular diseases (CVDs) are also characterized by insulin resistance, a pro-oxidative and pro-inflammatory state, as well as a dysregulation of the expression of various factors responsible for the homeostasis of redox and inflammatory environment [62]